In its quarterly activities report for the period ended 30 September 2026, Titomic reported a A$16.5 million equity raise from institutional investors. The company said EXIM had approved a US$10.3 million, or about A$14.7 million, loan to support expansion of advanced manufacturing capabilities in Huntsville, Alabama.
Titomic said the EXIM financing is intended to support acquisition of an integrated high-pressure cold-spray production cell at its Huntsville facility. The company said the loan remains subject to executed loan documentation and expects an initial drawdown to be material, although calculations had not been finalised.
The company reported cash and cash equivalents of A$18.145 million at quarter end, with operating cash outflows of A$10.441 million during the quarter. Titomic also said it had announced 11 new US orders and six European orders received since September.
Source: Download TTT official ASX announcement, 2026-10-29.
Photograph from Titomic’s Quarterly Activities Report announcement dated October 29, 2026.